Oregon Health & Science University: Research to Revenue

Oregon Health & Science University

Summit Venture Studio

Research to Revenue Report

Summit Venture Studio (SVS) Opportunities

SVS has identified 4 commercialization opportunities from Oregon Health & Science University and scored them based on our proprietary metrics and rubrics.

The SVS model is to identify the top 1% of commercialization opportunities and start companies around them.

Please connect with SVS if you would like to engage with us in our startup and investment efforts.

Return on Research (ROR) Analysis

Commercialization Revenue per Research Dollar

Top Universities by Return on Research (ROR)

ROI Ratio: Commercialization Revenue ÷ Research Funding

University Innovation Analysis

Total Innovation Scores by Institution

Top Universities by Innovation Score

180+ High Innovation

150-179 Strong Innovation

130-149 Moderate Innovation

100-129 Emerging Innovation

130+ total score considered high innovation impact

SVS Innovation Index

Proprietary Assessment of Oregon Health & Science University's Innovation Ecosystem
Score out of 100. Benchmark: Top 50 U.S. research institutions.
A score of 90/100 can be read "doing better than 90% of schools benchmarked"

Innovation Visibility

75/100

Definition: Media mentions, publication count, and global research visibility metrics

Startup Momentum

7/100

Definition: Growth in patents, funding, and startup formation

Ecosystem Strength

64/100

Definition: Tech transfer infrastructure and support systems

Innovation Legacy

A Timeline of Groundbreaking Discoveries

Innovation Timeline

Founded

1887

First Nobel

2009

First Patent

1973

First IPO

N/A

2022-2024

Cancer diagnostic breakthrough

2025

Today

Notable Commercialization Outcomes

Nobel Prizes

1974

First Patent

First technology patent issued

1974

First Startup

First startup launched

1981

Drug Licensing

Key drug licensed commercially

1990s

Biotech Spinout

Successful biotech company formed

2000s

Medical Device

Innovative device commercialized

2010s

Competitive Benchmarking

Oregon Health & Science University vs. Peer Research Universities

Oregon Health & Science University vs Peers Comparison

Metric	Oregon Health & Science University (FY2023)	Peer Average	Elite Average
Annual R&D Expenditure	$518M	$855M	$1,675M
New Inventions Disclosed	0	200	400
Startups Formed	3	7	10
Visibility Index	19	12	23
Licensing Revenue	$10M	$17M	$46M

Note: Peer Average = Median value among U.S. R1 research universities. Elite Average = Top 10 ranked U.S. research universities.

Emerging Opportunities

1. Precision Oncology Innovations Revolutionizing Cancer Treatment Outcomes

OHSU’s targeted therapies address cancer’s complexity, improving survival rates and reducing side effects, meeting growing demand for personalized, effective oncology solutions globally.

2. Advanced Neurodegenerative Disease Biomarkers for Early Diagnosis

OHSU’s biomarker technologies enable early detection of Alzheimer’s and Parkinson’s, addressing urgent needs for timely intervention and scalable diagnostic tools worldwide.

3. Cutting-Edge Regenerative Medicine Using Stem Cell Therapies

OHSU pioneers scalable stem cell treatments to repair damaged tissues, offering transformative solutions for chronic diseases with significant market growth potential.

4. AI-Driven Medical Imaging Enhancing Diagnostic Accuracy

OHSU’s AI algorithms improve medical image interpretation efficiency and precision, reducing diagnostic errors and healthcare costs, with broad applicability across healthcare systems.

5. Innovative Infectious Disease Vaccines Addressing Global Health Threats

OHSU develops novel vaccine platforms targeting emerging pathogens, providing scalable, rapid-response solutions vital for pandemic preparedness and global immunization efforts.

6. Next-Generation Biomedical Devices for Minimally Invasive Surgery

OHSU’s advanced surgical tools enhance precision and patient recovery, offering scalable technologies with competitive advantages in the expanding minimally invasive surgery market.